Article

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

2005-03-25

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 922dadec-cdcd-500c-b050-31f20abfa1d5
DOI: 10.1016/s0140-6736(05)74230-6

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disordersDOI 10.1016/s0140-6736(05)74230-6Read

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disordersSemantic proximity Read

A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospectsSemantic proximity Read

[JAK2 mutation in myeloproliferative disorders].Semantic proximity Read

<i>JAK2</i>Mutations in Myeloproliferative DisordersSemantic proximity Read

[JAK2 gene mutation in chronic myeloproliferative disorders].Semantic proximity Read

Update on the impact of the JAK2 mutation on signalling pathways in myeloproliferative disorders.Semantic proximity Read

[Pathogenetic role of JAK2 gene mutation in chronic myeloproliferative disorders].Semantic proximity Read

[A recurrent mutation of the JAK2 gene in chronic myeloproliferative disorders].Semantic proximity Read

[Myeloproliferative diseases caused by Jak2 gene mutation].Semantic proximity Read

BCR/ABL-negative chronic myeloproliferative disorders: JAK2 mutation and beyond.Semantic proximity Read

[Research progress on gene mutation of jak2].Semantic proximity Read

The JAK2(V617F) tyrosine kinase mutation in myeloproliferative disorders: Summary of published literature and a perspective.Semantic proximity Read